← Eichor
Study identifier: NCT07717385 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Sleep More, Stress Less: 90-Day Trial of Neuralli Mood

Condition: Psychological Stress · Sleep Disturbance · Anxiety Symptoms  ·  Sponsor: Efforia, Inc

PhaseNA
Planned participants100
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersYes

About this study

This decentralized, single-arm study evaluates the effects of 90 days of daily Neuralli Mood supplementation on perceived stress, sleep disturbance, mood, anxiety, depressive symptoms, happiness, and occupational burnout in adults experiencing stress or occasional sleep disruption. Participants serve as their own controls, completing validated self-report measures before beginning supplementation and again after the 90-day intervention, with safety and adherence check-ins during the study.

This description comes directly from the study's public registry record.

Talk to the study team

Matthew Amsden  ·  +13232844626  ·  help@efforia.com

Always discuss trial participation with your own doctor first.

Locations (1)

Efforia - Decentralized United States StudyNew York, New York, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07717385